AAAAAA

   
Results: 1-9 |
Results: 9
Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes
Authors: Lakehal, F Dansette, PM Becquemont, L Lasnier, E Delelo, R Balladur, P Poupon, R Beaune, PH Housset, C
Citation: F. Lakehal et al., Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes, CHEM RES T, 14(6), 2001, pp. 694-701
Synthesis of sulfaphenazole derivatives and their use as inhibitors and tools for comparing the active sites of human liver cytochromes P450 of the 2C subfamily
Authors: Ha-Duong, NT Dijols, S Marques-Soares, C Minoletti, C Dansette, PM Mansuy, D
Citation: Nt. Ha-duong et al., Synthesis of sulfaphenazole derivatives and their use as inhibitors and tools for comparing the active sites of human liver cytochromes P450 of the 2C subfamily, J MED CHEM, 44(22), 2001, pp. 3622-3631
Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P4502C19
Authors: Ha-Duong, NT Dijols, S Macherey, AC Goldstein, JA Dansette, PM Mansuy, D
Citation: Nt. Ha-duong et al., Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P4502C19, BIOCHEM, 40(40), 2001, pp. 12112-12122
Interaction of new sulfaphenazole derivatives with human liver cytochrome P4502Cs: Structural determinants required for selective recognition by CYP2C9 and for inhibition of human CYP2Cs
Authors: Ha-Duong, NT Marques-Soares, C Dijols, S Sari, MA Dansette, PM Mansuy, D
Citation: Nt. Ha-duong et al., Interaction of new sulfaphenazole derivatives with human liver cytochrome P4502Cs: Structural determinants required for selective recognition by CYP2C9 and for inhibition of human CYP2Cs, ARCH BIOCH, 394(2), 2001, pp. 189-200
HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins
Authors: Dansette, PM Jaoen, M Pons, C
Citation: Pm. Dansette et al., HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins, EXP TOX PAT, 52(2), 2000, pp. 145-148
Opposite behaviors of reactive metabolites of tienilic acid and its isomertoward liver proteins: Use of specific anti-tienilic acid-protein adduct antibodies and the possible relationship with different hepatotoxic effects of the two compounds
Authors: Bonierbale, E Valadon, P Pons, C Desfosses, B Dansette, PM Mansuy, D
Citation: E. Bonierbale et al., Opposite behaviors of reactive metabolites of tienilic acid and its isomertoward liver proteins: Use of specific anti-tienilic acid-protein adduct antibodies and the possible relationship with different hepatotoxic effects of the two compounds, CHEM RES T, 12(3), 1999, pp. 286-296
Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: Particular efficiency and regioselectivity of P4502Cs
Authors: Mancy, A Antignac, M Minoletti, C Dijols, S Mouries, V Duong, NTH Battioni, P Dansette, PM Mansuy, D
Citation: A. Mancy et al., Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: Particular efficiency and regioselectivity of P4502Cs, BIOCHEM, 38(43), 1999, pp. 14264-14270
Comparison of the substrate specificities of human liver cytochrome p450s 2C9 and 2C18: Application to the design of a specific substrate of CYP2C18
Authors: Minoletti, C Dijols, S Dansette, PM Mansuy, D
Citation: C. Minoletti et al., Comparison of the substrate specificities of human liver cytochrome p450s 2C9 and 2C18: Application to the design of a specific substrate of CYP2C18, BIOCHEM, 38(24), 1999, pp. 7828-7836
Drug-induced immunotoxicity
Authors: Dansette, PM Bonierbale, E Minoletti, C Beaune, PH Pessayre, D Mansuy, D
Citation: Pm. Dansette et al., Drug-induced immunotoxicity, EUR J DRUG, 23(4), 1998, pp. 443-451
Risultati: 1-9 |